Home' Australasian BioTechnology : Vol 28 No 1 Contents Australasian BioTechnology | Volume 28 | Number 1
Australasian BioTechnology | Volume 28 | Number 1 B
excretion and pharmacokinetic properties of drug
candidates to enable their further translation and entry into
Centre for Integrated Preclinical Drug Development
The University of Queensland’s CIPDD offers expertise for
drug development, including good laboratory practice (GLP)
preclinical studies, including pharmacokinetic and toxicology
studies, and specialist expertise in in-vivo efficacy profiling.
Preclinical Imaging Research Laboratory (PIRL), South
Based at the South Australian Health and Medical Research
Institute (SAHMRI), PIRL offers a variety of preclinical
services, including pharmacokinetic/pharmacodynamic (PK/
PD), plus imaging and experimental surgery.
Centre for Clinical Diagnostics (CCD)
Located at The University of Queensland’s Centre for Clinical
Research, CCD provides ISO-accredited development and
optimisation of in-vitro diagnostic medical devices.
Clinical trial support
Australia New Zealand Clinical Trials Registry (ANZCTR)
ANZCTR is an online register of clinical trials undertaken
in Australia in a variety of areas, and provides a detailed
picture of clinical trial research in Australia.
ACRF Cancer Genomics Facility
Based at the Centre for Cancer Biology, this facility provides
a full range of genomics and bioinformatics services to
support biomarker discovery and personalised medicine.
This facility within QIMR Berghofer offers ISO-accredited
somatic and germline analysis by whole genome and exome
sequencing, and gene expression services to clinicians,
companies and researchers.
Kinghorn Centre for Clinical Genomics
This centre, based at the Garvan Institute, offers ISO-
accredited whole-genome sequencing to translate genomics
to the clinic, as well as offering bioinformatics and data
Paediatric Trials Network Australia (PTNA)
PTNA brings together paediatric researchers in Australia to
facilitate paediatric clinical trials using WebSpirit, which is
advanced clinical-trial data-management software.
Peter MacCallum Molecular Pathology Laboratory
The Peter MacCallum Cancer Centre offers ISO-accredited,
state-of-the-art protein, RNA and DNA molecular pathology,
providing high-throughput diagnostic molecular services on
multiple test platforms.
Q-Pharm Clinical Trials
Q-Pharm specialises in early-phase clinical trials, including
first-in-human, biosimilar, PK/PD, vaccine, and challenge
studies. Q-Pharm operates state-of-the-art facilities within
the Royal Brisbane and Women’s Hospital.
Informatics and support services
BioGrid operates a federated data-sharing platform for
collaborative translational research, providing secure
infrastructure that links privacy-protected and ethically-
approved data with a network of health collaborators.
QIMR Berghofer Scientific Services
QIMR Berghofer’s core suite of integrated scientific services
are available to external users, including bioanalytics, flow
cytometry, histology, microscopy, proteomics, sample
processing and sequencing.
QIMR Berghofer Statistics Unit
This team of experts provides statistical consultancy and
research collaboration services to medical and clinical
researchers. Available services range from laboratory
research to clinical trials, epidemiology and biomarker
Victorian Cancer Biobank (VCB)
The VCB is a not-for-profit consortium of tissue banks that
provides high-quality, ethically obtained biospecimens for
researchers. Since 2006, more than 19,000 individuals have
donated to the Biobank, which has prepared more than
Visit www.therapeuticpipeline.com to find out more about
the Pipeline, including the Pipeline Navigator, an innovative
online map of therapeutic capability providers, and the Pipeline
Accelerator, a voucher-based scheme to support project access
to Pipeline capabilities.
Contact: Dr Stuart Newman, CEO
Phone: +61 (0)40 2345 736
More on TIA: www.therapeuticinnovation.com.au
The Pipeline Navigator (above) is an interactive online map of Pipeline
members and their capabilities.
503481E_Therapeutic Innovation I 2392.indd 2
27/3/18 4:19 pm
Links Archive Vol 27 No 3 Vol 28 No 2 Navigation Previous Page Next Page